Pharmaceuticals, medical
products and healthcare

News

Date	Topic
8/3/2010	Freshfields announces association with The Law Firm of Salah Al-Hejailan in Saudi Arabia
12/11/2009	Freshfields advises Advent on acquisition of Median in largest German buy-out deal to date
28/9/2009	Freshfields advises Solvay on €5.2bn sale of pharmaceutical business
11/6/2009	Litigation on the cards as firms look to sweat and protect IP assets during downturn
5/3/2009	Freshfields advises Roche on record bond issuance
22/1/2009	Freshfields advises Fresenius on $860m equivalent high yield bond issue
19/12/2008	Freshfields advises Wyeth Pharmaceuticals on its acquisition of Thiakis Limited
9/5/2008	Lord Darzi’s five pledges create the opportunity for increasing the pace of change but also risk creating increased costs for both the NHS and private sector providers, says Freshfields Bruckhaus Deringer
16/4/2008	Roche announces acquisition of UK biotech company Piramed
5/9/2007	Freshfields advises Morgan Stanley Real Estate on $1.1bn acquisition of Sunrise Senior Living
13/7/2007	Freshfields advises Cinven on acquisition of USP Hospitales for €675m
19/6/2007	Cinven reaches agreement to acquire BUPA's hospitals for £1.44bn
26/4/2007	Freshfields advises AstraZeneca on acquisition of Medimmune
15/1/2007	Kodak to sell Health Group to Onex for up to $2.55bn

Freshfields announces association with The Law Firm of Salah Al-Hejailan in Saudi Arabia View

Freshfields advises Advent on acquisition of Median in largest German buy-out deal to date View

Life sciences: China View

Class actions in the EU: a threat to the life sciences industry? View

Life Sciences Law Firm of the Year - FT/Mergermarket M&A Awards (2007)